Fig. 3From: Adjuvant therapy for retroperitoneal sarcoma: a meta-analysisForest plot and pooled analysis of hazard ratio for overall survival (OS) (a), recurrence-free survival (RFS) (b), and metastasis-free survival (MFS) (c) in RPS patients with adjuvant chemotherapyBack to article page